
1. Malar J. 2015 Sep 18;14:358. doi: 10.1186/s12936-015-0888-8.

Nrf2-driven CD36 and HO-1 gene expression in circulating monocytes correlates
with favourable clinical outcome in pregnancy-associated malaria.

Aubouy A(1), Olagnier D(2)(3), Bertin G(4), Ezinmegnon S(5), Majorel C(6)(7),
Mimar S(8), Massougbodji A(9), Deloron P(10), Pipy B(11), Coste A(12).

Author information: 
(1)Institut de Recherche pour le Développement (IRD), Université Paul Sabatier
Toulouse III, UMR 152 Pharma-Dev, CHU Rangueil, Bâtiment L1, 1 Avenue du Pr Jean 
Poulhès, 31059, Toulouse, France. agnes.aubouy@ird.fr.
(2)Institut de Recherche pour le Développement (IRD), Université Paul Sabatier
Toulouse III, UMR 152 Pharma-Dev, CHU Rangueil, Bâtiment L1, 1 Avenue du Pr Jean 
Poulhès, 31059, Toulouse, France. david.olagnier@mail.mcgill.ca.
(3)Lady Davis Institute-Jewish General Hospital, McGill University, Montreal,
Canada. david.olagnier@mail.mcgill.ca.
(4)Institut de Recherche pour le Développement (IRD), PRES Sorbonne Paris Cité,
Université Paris Descartes, UMR 216 Mère et enfant face aux infections
tropicales, Paris, France. gwladys.bertin@ird.fr.
(5)Centre d'Etude et de Recherche sur le Paludisme Associé à la Grossesse et
l'Enfance (CERPAGE), Cotonou, Benin. ezinmegnon.sem@gmail.com.
(6)Institut de Recherche pour le Développement (IRD), Université Paul Sabatier
Toulouse III, UMR 152 Pharma-Dev, CHU Rangueil, Bâtiment L1, 1 Avenue du Pr Jean 
Poulhès, 31059, Toulouse, France. clarisse.majorel@ird.fr.
(7)Laboratoire Insulaire du Vivant et de l'Environnement (LIVE-EA 4243),
Université de la Nouvelle-Caledonie (UNC), Nouméa, New Caledonia.
clarisse.majorel@ird.fr.
(8)Institut de Recherche pour le Développement (IRD), Université Paul Sabatier
Toulouse III, UMR 152 Pharma-Dev, CHU Rangueil, Bâtiment L1, 1 Avenue du Pr Jean 
Poulhès, 31059, Toulouse, France. mimar.saliha1@free.fr.
(9)Centre d'Etude et de Recherche sur le Paludisme Associé à la Grossesse et
l'Enfance (CERPAGE), Cotonou, Benin. massougbodjiachille@yahoo.fr.
(10)Institut de Recherche pour le Développement (IRD), PRES Sorbonne Paris Cité, 
Université Paris Descartes, UMR 216 Mère et enfant face aux infections
tropicales, Paris, France. philippe.deloron@ird.fr.
(11)Institut de Recherche pour le Développement (IRD), Université Paul Sabatier
Toulouse III, UMR 152 Pharma-Dev, CHU Rangueil, Bâtiment L1, 1 Avenue du Pr Jean 
Poulhès, 31059, Toulouse, France. bernard.pipy@inserm.fr.
(12)Institut de Recherche pour le Développement (IRD), Université Paul Sabatier
Toulouse III, UMR 152 Pharma-Dev, CHU Rangueil, Bâtiment L1, 1 Avenue du Pr Jean 
Poulhès, 31059, Toulouse, France. agnes.coste@univ-tlse3.fr.

BACKGROUND: Pregnancy-associated malaria (PAM) constitutes one of the most severe
forms of malaria infection leading to fetal growth restriction and high risk of
infant death. The severity of the pathology is largely attributed to the
recruitment of monocytes and macrophages in the placenta which is evidenced by
dysregulated inflammation found in placental blood. Importantly, CD36(+)
monocytes/macrophages are also thought to participate in the tight control of the
pro- and anti-inflammatory responses following Plasmodium detection through
elimination of apoptotic cells and malaria-infected erythrocytes, internalization
and recycling of oxidized forms of low-density lipoprotein and collaboration with
TLR2 in pro-inflammatory response. Interestingly, previous work demonstrated that
CD36 expression was upregulated on inflammatory macrophages following stimulation
of the Nrf2 transcription factor, whilst the PPARγ pathway was inhibited and
non-functional in the same inflammatory conditions. This current study examined
the possible role of Nrf2-driven gene expression, CD36 and Haem-Oxygenase-1
(HO-1), in PAM clinical outcomes.
METHODS: Clinical data and biological samples including peripheral blood
mononuclear cells were collected from 27 women presenting PAM. Polychromatic flow
cytometry was used to characterize innate immune cell subpopulations and quantify
CD36 protein expression level on monocytes. mRNA levels of CD36, PPARγ, Nrf2 and 
HO-1 were determined by qPCR and related to clinical outcomes. Finally, the
capacity of monocytes to modulate CD36 expression upon rosiglitazone or
sulforaphane treatment, two respective PPARγ or Nrf2 activators, was also
investigated.
RESULTS: The CD36 receptor, mostly expressed by CD14(+) circulating monocytes,
statistically correlated with increased infant birth weights. Interestingly, mRNA
levels of the transcription factor Nrf2 and the enzyme HO-1 also correlated with 
lower parasitaemia and increased infant birth weight, while PPARγ mRNA levels did
not. Finally, monocytes isolated from low infant birth weight pregnant women were
capable of up-regulating CD36 via the Nrf2 pathway ex vivo.
CONCLUSIONS: Altogether these results suggest that Nrf2-driven CD36 and HO-1
expression on innate immune cells could contribute to a protective and
detoxifying mechanism during PAM. More powered and mechanistical studies are
however needed to strengthen the conclusions of this study.

DOI: 10.1186/s12936-015-0888-8 
PMCID: PMC4575452
PMID: 26385579  [Indexed for MEDLINE]

